-
1
-
-
0037366464
-
Asian-Pacific consensus statement on the management of chronic hepatitis B: An update
-
Liaw YF Leung N Guan R Lau GK Merican I Asian-Pacific consensus statement on the management of chronic hepatitis B: an update J Gastroenterol Hepatol 2003 18 3 239 245
-
(2003)
J Gastroenterol Hepatol
, vol.18
, Issue.3
, pp. 239-245
-
-
Liaw, Y.F.1
Leung, N.2
Guan, R.3
Lau, G.K.4
Merican, I.5
-
2
-
-
0025347975
-
A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. the Hepatitis Interventional Therapy Group
-
Perrillo RP Schiff ER Davis GL et al A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group N Engl J Med 1990 323 5 295 301
-
(1990)
N Engl J Med
, vol.323
, Issue.5
, pp. 295-301
-
-
Perrillo, R.P.1
Schiff, E.R.2
Davis, G.L.3
Al, E.4
-
3
-
-
0033037480
-
Interferon alfa for chronic hepatitis B infection: Increased efficacy of prolonged treatment. the European Concerted Action on Viral Hepatitis (EUROHEP)
-
Janssen HL Gerken G Carreno V et al Interferon alfa for chronic hepatitis B infection: increased efficacy of prolonged treatment. The European Concerted Action on Viral Hepatitis (EUROHEP) Hepatology 1999 30 1 238 243
-
(1999)
Hepatology
, vol.30
, Issue.1
, pp. 238-243
-
-
Janssen, H.L.1
Gerken, G.2
Carreno, V.3
Al, E.4
-
4
-
-
0036896130
-
HBV genotype B is associated with better response to interferon therapy in HBeAg (+) chronic hepatitis than genotype C
-
Wai CT Chu CJ Hussain M Lok AS HBV genotype B is associated with better response to interferon therapy in HBeAg (+) chronic hepatitis than genotype C Hepatology 2002 36 6 1425 1430
-
(2002)
Hepatology
, vol.36
, Issue.6
, pp. 1425-1430
-
-
Wai, C.T.1
Chu, C.J.2
Hussain, M.3
Lok, A.S.4
-
5
-
-
0033890782
-
Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays
-
Pas SD Fries E De Man RA Osterhaus AD Niesters HG Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays J Clin Microbiol 2000 38 8 2897 2901
-
(2000)
J Clin Microbiol
, vol.38
, Issue.8
, pp. 2897-2901
-
-
Pas, S.D.1
Fries, E.2
De Man, R.A.3
Osterhaus, A.D.4
Niesters, H.G.5
-
6
-
-
0033816667
-
Interferon-alpha therapy in chronic hepatitis B: Early monitoring of hepatitis B e antigen may help to decide whether to stop or to prolong therapy
-
Heijtink RA Janssen HL Hop WC Osterhaus AD Schalm SW Interferon-alpha therapy in chronic hepatitis B: early monitoring of hepatitis B e antigen may help to decide whether to stop or to prolong therapy J Viral Hepat 2000 7 5 382 386
-
(2000)
J Viral Hepat
, vol.7
, Issue.5
, pp. 382-386
-
-
Heijtink, R.A.1
Janssen, H.L.2
Hop, W.C.3
Osterhaus, A.D.4
Schalm, S.W.5
-
7
-
-
0027486290
-
Monitoring of antiviral therapy with quantitative evaluation of HBeAg: A comparison with HBV DNA testing
-
Perrillo R Mimms L Schechtman K Robbins D Campbell C Monitoring of antiviral therapy with quantitative evaluation of HBeAg: a comparison with HBV DNA testing Hepatology 1993 18 6 1306 1312
-
(1993)
Hepatology
, vol.18
, Issue.6
, pp. 1306-1312
-
-
Perrillo, R.1
Mimms, L.2
Schechtman, K.3
Robbins, D.4
Campbell, C.5
-
8
-
-
0032940812
-
Early prediction of response in interferon monotherapy and in interferon-ribavirin combination therapy for chronic hepatitis C: HCV RNA at 4 weeks versus ALT
-
Brouwer JT Hansen BE Niesters HG Schalm SW Early prediction of response in interferon monotherapy and in interferon-ribavirin combination therapy for chronic hepatitis C: HCV RNA at 4 weeks versus ALT J Hepatol 1999 30 2 192 198
-
(1999)
J Hepatol
, vol.30
, Issue.2
, pp. 192-198
-
-
Brouwer, J.T.1
Hansen, B.E.2
Niesters, H.G.3
Schalm, S.W.4
-
9
-
-
0037179698
-
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
-
Fried MW Shiffman ML Reddy KR et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection N Engl J Med 2002 347 13 975 982
-
(2002)
N Engl J Med
, vol.347
, Issue.13
, pp. 975-982
-
-
Fried, M.W.1
Shiffman, M.L.2
Reddy, K.R.3
-
10
-
-
0036829649
-
Management of hepatitis C: 2002 - June 10-12, 2002
-
National Institutes of Health Consensus Development Conference Statement
-
National Institutes of Health Consensus Development Conference Statement Management of hepatitis C: 2002 - June 10-12, 2002 Hepatology 2002 36 5 Suppl. 1 3 20
-
(2002)
Hepatology
, vol.36
, Issue.5 SUPPL. 1
, pp. 3-20
-
-
-
11
-
-
0031419744
-
Serum HBeAg quantitation during antiviral therapy for chronic hepatitis B
-
Heijtink RA Kruining J Honkoop P et al. Serum HBeAg quantitation during antiviral therapy for chronic hepatitis B J Med Virol 1997 53 3 282 287
-
(1997)
J Med Virol
, vol.53
, Issue.3
, pp. 282-287
-
-
Heijtink, R.A.1
Kruining, J.2
Honkoop, P.3
-
12
-
-
0032922675
-
Quantitative detection of hepatitis B virus DNA in two international reference plasma preparations. Eurohep Pathobiology Group
-
Heermann KH Gerlich WH Chudy M Schaefer S Thomssen R Quantitative detection of hepatitis B virus DNA in two international reference plasma preparations. Eurohep Pathobiology Group J Clin Microbiol 1999 37 1 68 73
-
(1999)
J Clin Microbiol
, vol.37
, Issue.1
, pp. 68-73
-
-
Heermann, K.H.1
Gerlich, W.H.2
Chudy, M.3
Schaefer, S.4
Thomssen, R.5
-
13
-
-
0033971684
-
Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy
-
Stuyver L Van Geyt C De Gendt S et al Line probe assay for monitoring drug resistance in hepatitis B virus-infected patients during antiviral therapy J Clin Microbiol 2000 38 2 702 707
-
(2000)
J Clin Microbiol
, vol.38
, Issue.2
, pp. 702-707
-
-
Stuyver, L.1
Van Geyt, C.2
De Gendt, S.3
Al, E.4
-
14
-
-
0035010523
-
Management of hepatitis b: 2000-summary of a workshop
-
Lok AS Heathcote EJ Hoofnagle JH Management of hepatitis b: 2000-summary of a workshop Gastroenterology 2001 120 7 1828 1853
-
(2001)
Gastroenterology
, vol.120
, Issue.7
, pp. 1828-1853
-
-
Lok, A.S.1
Heathcote, E.J.2
Hoofnagle, J.H.3
-
15
-
-
0023710206
-
Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach
-
DeLong ER DeLong DM Clarke-Pearson DL Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 1988 44 3 837 845
-
(1988)
Biometrics
, vol.44
, Issue.3
, pp. 837-845
-
-
Delong, E.R.1
Delong, D.M.2
Clarke-Pearson, D.L.3
-
16
-
-
0037371186
-
Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: Relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase
-
van Nunen AB Hansen BE Suh DJ et al Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase Gut 2003 52 3 420 424
-
(2003)
Gut
, vol.52
, Issue.3
, pp. 420-424
-
-
Van Nunen, A.B.1
Hansen, B.E.2
Suh, D.J.3
Al, E.4
-
17
-
-
0031828962
-
Predictive value of aminotransferase and hepatitis B virus DNA levels on response to interferon therapy for chronic hepatitis B
-
Lok AS Ghany MG Watson G Ayola B Predictive value of aminotransferase and hepatitis B virus DNA levels on response to interferon therapy for chronic hepatitis B J Viral Hepat 1998 5 3 171 178
-
(1998)
J Viral Hepat
, vol.5
, Issue.3
, pp. 171-178
-
-
Lok, A.S.1
Ghany, M.G.2
Watson, G.3
Ayola, B.4
|